Zhang MC, Yan ZL, Wang JJ, Yao XQ. Onco Targets Ther. 2017;10:4339–4346.On page 4339, the correspondence was listed as:Correspondence: Xueqing YaoDepartment of General Surgery, Guangdong General Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan 2nd Road, Guangzhou, Guangdong 510080, ChinaTel +86 139 0238 8635Email yjb9211@21cn.comIt should have been:Correspondence: Xueqing Yao1,21Second Clinical Medical College of Southern Medical University, 1838 Guangzhou Avenue North, Guangzhou, Guangdong 510515, China; 2Department of General Surgery, Guangdong General Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan 2nd Road, Guangzhou, Guangdong 510080, ChinaTel +86 139 0238 8635Email yjb9211@21cn.comRead the orig...
Pan B, Han H, Wu L, et al. Onco Targets Ther. 2018;11:6741–6756.On page 6741, the authors&rsqu...
Chen C, Zhang Z, Li J, Sun Y. Onco Targets Ther. 2018;11: 6081–6090.On page 6089, the acknowle...
From Springer Nature via Jisc Publications RouterHistory: registration 2021-07-15, online 2021-07-22...
Gao XY, Zhang GH, Huang L. Onco Targets Ther. 2018;11: 1447–1456. On page 1447, ...
Rong J, Wang Q, Zhang Y, et al. Onco Targets Ther. 2018;11:6723–6730. On page 6723, Xiu-f...
Zhang T, Feng F, Zhao W, et al. Onco Targets Ther. 2018;11:2647–2656. On page 2647, affil...
From Europe PMC via Jisc Publications RouterHistory: ppub 2021-07-01, epub 2021-07-22Publication sta...
In the original version of this article [1], published on 7 November 2017, affiliation 18 has been i...
Zhou L, Gao Y, Cao W, et al. Infect Drug Resist. 2018;11:29–36.On page 29, the first and secon...
The authors regret that the affiliations for Dr A. De Toma and Dr G. Lo Russo were incorrect when th...
In this article, the authors’ first names and surnames were incorrectly listed in the wrong order. T...
Zhang Q, Zong L, Zhang H, et al. Onco Targets Ther. 2021;14:4275–4283. The authors have advise...
Erratum inCorrection to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors ...
Xie B, Sun LY, Cheng YJ, et al. Cancer Manag Res. 2018;10;3551–3560.On page 3551, the affiliat...
Zhao XZ, Wu XH. Onco Targets Ther. 2018;11:3609–3617.On page 3609, affiliation 2 should read a...
Pan B, Han H, Wu L, et al. Onco Targets Ther. 2018;11:6741–6756.On page 6741, the authors&rsqu...
Chen C, Zhang Z, Li J, Sun Y. Onco Targets Ther. 2018;11: 6081–6090.On page 6089, the acknowle...
From Springer Nature via Jisc Publications RouterHistory: registration 2021-07-15, online 2021-07-22...
Gao XY, Zhang GH, Huang L. Onco Targets Ther. 2018;11: 1447–1456. On page 1447, ...
Rong J, Wang Q, Zhang Y, et al. Onco Targets Ther. 2018;11:6723–6730. On page 6723, Xiu-f...
Zhang T, Feng F, Zhao W, et al. Onco Targets Ther. 2018;11:2647–2656. On page 2647, affil...
From Europe PMC via Jisc Publications RouterHistory: ppub 2021-07-01, epub 2021-07-22Publication sta...
In the original version of this article [1], published on 7 November 2017, affiliation 18 has been i...
Zhou L, Gao Y, Cao W, et al. Infect Drug Resist. 2018;11:29–36.On page 29, the first and secon...
The authors regret that the affiliations for Dr A. De Toma and Dr G. Lo Russo were incorrect when th...
In this article, the authors’ first names and surnames were incorrectly listed in the wrong order. T...
Zhang Q, Zong L, Zhang H, et al. Onco Targets Ther. 2021;14:4275–4283. The authors have advise...
Erratum inCorrection to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors ...
Xie B, Sun LY, Cheng YJ, et al. Cancer Manag Res. 2018;10;3551–3560.On page 3551, the affiliat...
Zhao XZ, Wu XH. Onco Targets Ther. 2018;11:3609–3617.On page 3609, affiliation 2 should read a...
Pan B, Han H, Wu L, et al. Onco Targets Ther. 2018;11:6741–6756.On page 6741, the authors&rsqu...
Chen C, Zhang Z, Li J, Sun Y. Onco Targets Ther. 2018;11: 6081–6090.On page 6089, the acknowle...
From Springer Nature via Jisc Publications RouterHistory: registration 2021-07-15, online 2021-07-22...